Revolution Medicines, Inc 10-Q for FY2023 Q2
Revolution Medicines, Inc. (RVMD)
10-Q
2023-08-08
For: 2023-06-30
View Original
Added on
April 10, 2026
About this 10-Q
Revolution Medicines, Inc filed this 10-Q on August 8, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).
Headline figures
Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $3.82M
- down 58.1% from $9.12M a year earlier
- Net loss
- $98.3M
- compared with a net loss of $61.22M a year earlier
- Diluted EPS
- -$0.92
- compared with -$0.82 a year earlier